1113P COLUMBUS 7-year update: A randomized, open-label, phase III trial of encorafenib (enco) + binimetinib (bini) vs vemurafenib (vemu) or enco in patients (pts) with BRAF V600–mutant melanoma
Schadendorf, D., Dummer, R., Flaherty, K.T., Robert, C., Arance Fernandez, A.M., de Groot, J.W., Garbe, C., Gogas, H., Gutzmer, R., Krajsova, I., Liszkay, G., Loquai, C., Mandalà, M., Yamazaki, N., Guenzel, C.A., Polli, A., Thakur, M., di Pietro, A., Ascierto, P.A.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
1090P Outcome impact of time from complete resection to start of adjuvant immunotherapy in stage III-IV melanoma patients
Martinez Recio, S., Molina Pérez, M.A., Muñoz Couselo, E., Sevillano Tripero, A.R., Martin-Liberal, J., Orrillo, M., Arance Fernandez, A.M., Aya Moreno, F., Fernández-Morales, L.A., Quindos Varela, M., Lesta, R., Barba Joaquín, A., Sullivan, I.G., Majem, M.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
Clinical outcomes of metastasic melanoma patients treated with ipilimumab and nivolumab: A single institution experience
Oberoi, H.K. Oberoi, Vila, C.M., Rodriguez, A., Coronel, D. Pesantez, Moreno, F. Aya, Puig, M.C. Font, Fernandez, A.M. Arance
Published in Annals of oncology (01.12.2019)
Published in Annals of oncology (01.12.2019)
Get full text
Journal Article
780TiP A phase I dose-escalation study to investigate the safety, efficacy, pharmacokinetics, and pharmacodynamic activity of CLN-619 (anti-MICA/MICB Antibody) alone and in combination with pembrolizumab in patients with advanced malignancies
Hamilton, E.P., Melero, I., Lugowska, I., Arance Fernandez, A.M., Vila Martinez, L., Powderly, J.D., Gutierrez, M., Serino, T., Mehta, N., Shapiro, I., Whalen, K., Michaelson, J., Jones, J., Janik, J.E., Moreno Garcia, V.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
786O Tumor biomarker analysis from COLUMBUS part 1: Encorafenib + binimetinib for BRAF V600E/K-mutant advanced or metastatic melanoma
Dummer, R., Pathan, N., Deng, S., Robert, C., Arance Fernandez, A.M., de Groot, J.W.B., Garbe, C., Gogas, H.J., Gutzmer, R., Krajsova, I., Liszkay, G., Loquai, C., Mandala, M., Schadendorf, D., Yamazaki, N., di Pietro, A., Xie, T., Ascierto, P.A., Flaherty, K.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
817P Nivolumab (NIVO) + relatlimab (RELA) vs NIVO in previously untreated metastatic or unresectable melanoma: Additional response outcomes from RELATIVITY-047
Hodi, F.S., Tawbi, H.A., Lipson, E.J., Schadendorf, D., Ascierto, P.A., Matamala, L.A., Salman, P., Gutierrez, E.C., Rutkowski, P., Gogas, H.J., Lao, C.D., Menezes, J., Dalle, S., Arance Fernandez, A.M., Grob, J.J., Keidel, S., Rodriguez, S., Wang, P., Dolfi, S., Long, G.V.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
602P COLUMBUS 7-year update: A randomized, open-label, phase III trial of encorafenib (Enco) + binimetinib (Bini) vs vemurafenib (Vemu) or Enco in patients (Pts) with BRAF V600-mutant melanoma
Haydon, A.M., Schadendorf, D., Dummer, R., Flaherty, K.T., Robert, C., Arance Fernandez, A.M., de Groot, J.W., Garbe, C., Gogas, H., Gutzmer, R., Krajsova, I., Liszkay, G., Loquai, C., Mandalà, M., Yamazaki, N., Guenzel, C.A., Polli, A., Thakur, M., Di Pietro, A., Ascierto, P.A.
Published in Annals of oncology (01.11.2023)
Published in Annals of oncology (01.11.2023)
Get full text
Journal Article
1083MO Brain metastases and survival evaluation in the SECOMBIT trial
Ascierto, P.A., Mandalà, M., Ferrucci, P.F., Guidoboni, M., Rutkowski, P., Ferraresi, V., Arance Fernandez, A.M., Guida, M., Maiello, E., Gogas, H., Richtig, E., Fierro, M.T., Lebbe, C., Helgadottir, H., Melero, I., Palmieri, G., Giannarelli, D., Grimaldi, A.M., Dummer, R., Chiarion Sileni, V.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
2246P Tumor-infiltrating lymphocites and gene expression across multiple cancer-types: A translational analysis from the SOLTI-1904-ACROPOLI study
Solis, E. Segui, Torres, E. Sanfeliu, Gonzalez-Farre, B., Pascual, T., Brasó-Maristany, F., Galván, P., Farre, X. González, Salvador, F., Felip, E., Garralda, E., Paz-Ares, L., Juan, M., Nin, R. Mesia, Fernandez, A.M. Arance, Cervantes, A., Martin-Liberal, J., Javierre, G. Villacampa, Tabernero, J., Prat, A.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
1089P Adjuvant nivolumab (NIVO) vs ipilimumab (IPI) in resected stage III/IV melanoma: 7-y results from CheckMate 238
Ascierto, P.A., Del Vecchio, M., Merelli, B., Gogas, H., Arance Fernandez, A.M., Dalle, S., Cowey, C.L., Schenker, M., Grob, J.J., Chiarion Sileni, V., Marquez-Rodas, I., Butler, M.O., Di Giacomo, A.M., Pe Benito, M., Soomro, R., Askelson, M., Weber, J.S., Larkin, J.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
2239P Gene expression profiling in tumors with and without tertiary lymphoid structures across cancer-types
Solis, E. Segui, Pascual, T., Torres, E. Sanfeliu, Gonzalez-farre, B., Brasó-Maristany, F., Farre, X. González, Salvador, F., Felip, E., Garralda, E., Paz-Ares, L., Otero, M.J., Nin, R. Mesia, Fernandez, A.M. Arance, Cervantes, A., Martin-Liberal, J., Gavilá-Gregori, J., Parraga, K. Amillano, Racca, F.E., Tabernero, J., Prat, A.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
1056P Efficacy of spartalizumab across multiple cancer types in patients with PD1-high mRNA expressing tumors (SOLTI-1904 ACROPOLI)
Prat, A., Pascual, T., Juan, M., Paz-Ares, L., Felip, E., Garralda, E., Gonzalez-farre, B., Arance Fernandez, A.M., Martin-Liberal, J., López, A., Izarzugaza Peron, Y., Garcia-Corbacho, J., Saura Manich, C., Hierro, C., Sanfeliu Torres, E., Cejalvo, J.M., Salvador, F., Mesia Nin, R., Cervantes, A., Tabernero, J.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
1106P Anti-PD-1 (PD1) monotherapy or in combination with anti-CTLA-4 for metastatic melanoma (MM) patients (pts) with liver metastases (mets)
Pires da Silva, I., Li, I., Ugurel-Becker, S., Serra-Bellver, P., Andhale, A., Burnette, H., Aya, F., Conway, J., Carlino, M., Menzies, A.M., Weichenthal, M., Mohr, P., Gutzmer, R., Arance Fernandez, A.M., Johnson, D., Lorigan, P., Schadendorf, D., Lo, S., Long, G.V.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
149P KEYNOTE-629: Efficacy of pembrolizumab (Pembro) per immune-related RECIST (irRECIST) in locally advanced (LA) and recurrent or metastatic (R/M) cutaneous squamous cell carcinoma (cSCC)
Munoz Couselo, E., Hughes, B.G.M., Bratland, Å., Gutzmer, R., Roshdy, O., González Mendoza, R., Schachter, J., Arance Fernandez, A.M., Grange, F., Meyer, N., Joshi, A.J., Billan, S., Grob, J.J., Zhang, P., Gumuscu, B., Swaby, R., Mortier, L.
Published in Annals of oncology (01.12.2021)
Published in Annals of oncology (01.12.2021)
Get full text
Journal Article
826P Encorafenib and binimetinib followed by radiotherapy for patients with symptomatic BRAF mutated melanoma brain metastases: GEM1802/E-BRAIN clinical trial
Marquez-Rodas, I., Arance Fernandez, A.M., Berciano Guerrero, M.A., Garcia Castano, A., Alamo De La Gala, M.D.C., Gonzalez Cao, M., Sanchez Mauriño, P., Diaz Beveridge, R.P., Valduvieco, I., Delgado, R., Prada, P.J., Puertas, E., Romero, J.L., Conde, A., Alvarez, A., Berrocal, A.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
LBA41 Phase II study SECOMBIT (sequential combo immuno and target therapy study): 4-years OS data and preliminary biomarkers evaluation
Ascierto, P.A., Mandala, M., Ferrucci, P.F., Guidoboni, M., Rutkowski, P., Ferraresi, V., Fernandez, A.M. Arance, Guida, M., Maiello, E., Gogas, H.J., Richtig, E., Fierro, M.T., Lebbe, C., Helgadottir, H., Melero, I., Palmieri, G., Giannarelli, D., Grimaldi, A.M., Dummer, R., Sileni, V. Chiarion
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
LBA44 Lenvatinib (len) plus pembrolizumab (pembro) for advanced melanoma (MEL) that progressed on a PD-1 or PD-L1 inhibitor: Initial results of LEAP-004
Fernandez, A.M. Arance, O'Day, S.J., Merino, L. de la Cruz, Petrella, T., Jamal, R., Ny, L., Carneiro, A., Berrocal, A., Márquez-Rodas, I., Spreafico, A., Victoria Atkinson, V., Costa Svedman, F., Smith, A.D., Chen, K., Diede, S.J., Krepler, C., Long, G.V.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
1127P Correlation of BRAF mutation status in circulating tumour DNA (ctDNA) with tumour biopsy and clinical outcomes in COLUMBUS
Robert, C., Flaherty, K.T., Gogas, H.J., Fernandez, A.M. Arance, Mandala, M., Liszkay, G., Garbe, C., Schadendorf, D., Krajsova, I., Gutzmer, R., de Groot, J.W.B., Dutriaux, C., Loquai, C., Harney, A., Kiprilov, E., Pickard, M.D., Cantey-Kiser, J., Dummer, R., Ascierto, P.A.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
LBA40 SECOMBIT: The best sequential approach with combo immunotherapy [ipilimumab (I) /nivolumab (N)] and combo target therapy [encorafenib (E)/binimetinib (B)] in patients with BRAF mutated metastatic melanoma: A phase II randomized study
Ascierto, P.A., Mandala, M., Ferrucci, P.F., Rutkowski, P., Guidoboni, M., Arance Fernandez, A.M., Ferraresi, V., Maiello, E., Guida, M., Del Vecchio, M., Fierro, M.T., Queirolo, P., Lebbe, C., Helgadottir, H., Melero, I., Palmieri, G., Giannarelli, D., Grimaldi, A.M., Dummer, R., Chiarion Sileni, V.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
1025TiP SOLTI-1904: Efficacy of spartalizumab across multiple cancer-types in patients with PD1-high mRNA expressing tumors defined by a single and pre-specified cutoff (ACROPOLI)
Prat, A., Paz-Ares, L., Juan, M., Felip, E., Garralda, E., González-Farré, B., Arance Fernandez, A.M., Martin-Liberal, J., Gavilá, J., López González, A., Cejalvo, J.M., Izarzugaza, Y., Amillano, K., Garcia-Corbacho, J., Saura Manich, C., Salvador, F., Pascual, T., Mesía, R., Cervantes, A., Tabernero, J.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article